BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24810138)

  • 1. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.
    Bewtra M; Brensinger CM; Tomov VT; Hoang TB; Sokach CE; Siegel CA; Lewis JD
    Inflamm Bowel Dis; 2014 Jun; 20(6):1070-8. PubMed ID: 24810138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
    Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Golovics PA; Gonczi L; Reinglas J; Verdon C; Pundir S; Afif W; Wild G; Bitton A; Bessissow T; Lakatos PL
    Dig Dis Sci; 2022 Jul; 67(7):3089-3095. PubMed ID: 34286411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo Score and the Simple Clinical Colitis Activity Index.
    Bewtra M
    Inflamm Bowel Dis; 2015 Jan; 21(1):E1. PubMed ID: 25479459
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on an optimized patient-reported ulcerative colitis disease activity measure derived from the mayo score and the simple clinical colitis activity index.
    Walmsley RS
    Inflamm Bowel Dis; 2014 Dec; 20(12):E25-6. PubMed ID: 25374290
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Marín-Jiménez I; Nos P; Domènech E; Riestra S; Gisbert JP; Calvet X; Cortés X; Iglesias E; Huguet JM; Taxonera C; Fernández R; Carpio D; Gutiérrez A; Guardiola J; Laria LC; Sicilia B; Bujanda L; Cea-Calvo L; Romero C; Rincón Ó; Juliá B; Panés J
    Am J Gastroenterol; 2016 Feb; 111(2):261-8. PubMed ID: 26753886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices.
    van Wassenaer EA; van Rijn RR; Zwetsloot SLM; de Voogd FAE; van Schuppen J; Kindermann A; de Meij TGJ; van Limbergen JE; Gecse KB; D'Haens GR; Benninga MA; Koot BGP
    Inflamm Bowel Dis; 2023 Aug; 29(8):1217-1222. PubMed ID: 36149272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score.
    Jairath V; Jeyarajah J; Zou G; Parker CE; Olson A; Khanna R; D'Haens GR; Sandborn WJ; Feagan BG
    Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):63-70. PubMed ID: 30343116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Castaneda G; Liu B; Torres S; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Oct; 62(10):2876-2881. PubMed ID: 28856475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.
    Lewis JD; Chuai S; Nessel L; Lichtenstein GR; Aberra FN; Ellenberg JH
    Inflamm Bowel Dis; 2008 Dec; 14(12):1660-6. PubMed ID: 18623174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining relapse of ulcerative colitis using a symptom-based activity index.
    Jowett SL; Seal CJ; Phillips E; Gregory W; Barton JR; Welfare MR
    Scand J Gastroenterol; 2003 Feb; 38(2):164-71. PubMed ID: 12678333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.
    de Jong DC; Löwenberg M; Koumoutsos I; Ray S; Mawdsley J; Anderson S; Sanderson JD; Gecse K; Ponsioen CY; D'Haens GR; Irving PM; Samaan MA
    Inflamm Bowel Dis; 2019 Apr; 25(5):937-944. PubMed ID: 30329045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
    Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DUBLIN [Degree of Ulcerative colitis Burden of Luminal Inflammation] Score, a Simple Method to Quantify Inflammatory Burden in Ulcerative Colitis.
    Rowan CR; Cullen G; Mulcahy HE; Sheridan J; Moss AC; Ryan EJ; Doherty GA
    J Crohns Colitis; 2019 Oct; 13(11):1365-1371. PubMed ID: 30911757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.
    Samaan MA; Cunningham G; Tamilarasan AG; Beltran L; Pavlidis P; Ray S; Mawdsley J; Anderson SH; Sanderson JD; Arkir Z; Irving PM
    Aliment Pharmacol Ther; 2020 Jul; 52(2):292-302. PubMed ID: 32506695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.